<DOC>
	<DOCNO>NCT01201772</DOCNO>
	<brief_summary>A high degree platelet inhibition remain goal peri-interventional long-term anti-thrombotic therapy patient coronary artery disease . In clinical practice , patient undergo percutaneous coronary intervention stent implantation already clopidogrel therapy get re-loaded clopidogrel . This base prior observation show high inhibition platelet aggregation may achieve give load dose clopidogrel patient coronary artery disease chronic clopidogrel therapy . However , date unknown great inhibition platelet aggregation achieve add prasugrel load dose patient chronic prasugrel therapy . Therefore , understand pharmacodynamic implication prasugrel re-load strategy patient already chronic prasugrel therapy useful .</brief_summary>
	<brief_title>Prasugrel Re-load Strategies</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Prasugrel Hydrochloride</mesh_term>
	<criteria>1 . Patients angiographically document coronary artery disease . 2 . Age 18 74 year 3 . On treatment prasugrel 10mg/daily least 14 day . 1 . Blood dyscrasia bleed diathesis 2 . Antiplatelet treatment clopidogrel ticlopidine 3 . Recent antiplatelet treatment ( &lt; 14 day ) glycoprotein IIb/IIIa antagonist 4 . Platelet count &lt; 100x106/ÂµL 5 . Active bleed hemodynamic instability . 6 . Unstable angina , acute recent ( &lt; 14 day ) myocardial infarction . 7 . Serum creatinine &gt; 2 mg/dL 8 . Baseline ALT &gt; 2.5 time upper limit normal 9 . Oral anticoagulation coumarin derivative 10 . History stroke , TIA intracranial bleeding 11 . Weight &lt; 60kg 12 . Pregnant female</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>74 Years</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>coronary artery disease</keyword>
	<keyword>percutaneous coronary revascularization</keyword>
	<keyword>prasugrel therapy</keyword>
</DOC>